The Pharmacy and Poisons Board (PPB) has granted, ION Kenya, which operates the MyDawa brand the first ever Retail License for an e-retailing pharmacy in Kenya.
Issuance of the license marks a major milestone for MyDawa which has other licenses that allows the organisation to operate as an online retail pharmacy. The move now provides the firm a full suite of retail services directly to patient from mydawa.com website and mobile app.
“It delights to break the news that we have secured the first ever pharmacy e-retailing license. Having identified a problem within the pharmaceutical industry supply chain two years ago, it gratifies that MyDawa concept, conceived to streamline the process of drug delivery to consumers shall now lead the way to convey to patients their prescribed medication,”
Neal O’Leary, Founder MyDawa.
“It delights to break the news that we have secured the first ever pharmacy e-retailing license,” said Neal O’Leary, the founder MyDawa initiative and chairman of ION Kenya who was flanked by Tony Wood, Managing Director, MyDawa, while talking to CIO East Africa in Nairobi.
“Having identified a problem within the pharmaceutical industry supply chain two years ago, it gratifies that MyDawa concept, conceived to streamline the process of drug delivery to consumers shall now lead the way to convey to patients prescribed medication,” said O’Leary.
With the hindsight of the company being a technology solutions oriented company, O’Leary asserted that a moment has come for patients to worry-free of getting quality drugs at affordable costs. The technology behind MyDawa allows one to enjoy the transparency as well as efficiency in the supply chain besides making it convenient for customers to procure medicine.
Being the pioneer e-retailing pharmacy licensee in Kenya is not only a major leap to MyDawa but more so to consumers of essential drugs prescribed by over 300 doctors who have partnered with MyDawa in the country so far. “This allows patients to upload prescriptions directly from their phones, where we will transcribe and fulfil them from our fulfilment centre ensuring that their products are securely and conveniently delivered,” said Wood.
Patient counselling will be provided in several ways including face-to-face, telephone and backed up with further online information that will ensure MyDawa makes even greater leap forward following its quest in achieving its mission of better patient outcomes in the steadily growing digital health marketplace.
The entry of MyDawa in the pharmaceutical products supply chain aims to address the lengthy long and quite often fragmented process. The reality on the ground shows that at virtually every stage that a pharmaceutical product changes hands, new costs are introduced which makes the costs of essential drugs highly prohibitive.
The timely licensing of the delivery of delivering prescribed drugs to patients with without any addition or hidden costs is lined to enhance efficiency in the health sector supply and by extension impact positively in the country now yearning for better services.